Mazen M. Dimachkie. “Optimizing Chronic Inflammatory Demyelinating Polyneuropathy Care With Subcutaneous Immunoglobulin: The Polyneuropathy and Treatment With Hizentra Open-Label Extension (PATH OLE) Study and Beyond”. RRNMF Neuromuscular Journal 3, no. 2 (June 22, 2022): 13–26. Accessed November 3, 2024. https://journals.ku.edu/rrnmf/article/view/16304.